Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Buffer Controlled Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102329318A reveals a buffered NaBH4 reduction method for tetrahydrofolic acid, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.